The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Valuation Is Forecasted For The Sickle Cell Disease Treatment Market By 2030 Starting From Its 2026 Size?
The sickle cell disease treatment market has seen rapid growth in recent years. It is projected to expand from $3.51 billion in 2025 to $4.11 billion in 2026, achieving a compound annual growth rate (CAGR) of 17.3%. This historical growth can be attributed to various factors such as the high prevalence of the disease in Africa and Americas, the limited availability of treatment options, the reliance on blood transfusions, advancements in hematology research, and a lack of early diagnostic awareness.
The sickle cell disease treatment market size is projected to experience substantial growth over the coming years. It is anticipated to expand to $7.99 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 18.1%. This expansion during the forecast period can be attributed to several factors, including the introduction of gene therapy solutions, the increased development of biologics and targeted drugs, the incorporation of predictive diagnostics, a rise in global healthcare initiatives, and the implementation of personalized treatment plans for patients. Noteworthy trends for the forecast period encompass the evolution of gene-editing therapies, the growing accessibility of hydroxyurea, the broadening scope of blood transfusion management, the adoption of advanced diagnostics for early detection, and the expansion of patient support and disease management programs.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13048&type=smp
Which Market Drivers Are Supporting The Expansion Of The Sickle Cell Disease Treatment Market?
The increasing number of blood and bone marrow transplants is anticipated to fuel the expansion of the sickle cell disease treatment market moving forward. This medical procedure involves replacing unhealthy blood-forming cells with healthy ones. The primary goal of a bone marrow transplant is to treat sickle cell diseases and cancers by infusing healthy bone marrow cells into an individual after their diseased bone marrow has been prepared to remove abnormal cells. These replacement cells can be sourced from the patient’s own body (an autologous transplant) or from a donor (an allogeneic transplant). For instance, in June 2024, the National Transplant Organization (ONT), a Spain-based independent coordinating agency, reported that in 2023, Spain augmented its Bone Marrow Donor Registry with 23,686 donors, an 8% increase compared to 2022, and performed a record 3,717 hematopoietic stem cell transplants, equivalent to 77.4 transplants per million population. Therefore, the growing number of blood and bone marrow transplants will significantly propel the sickle cell disease treatment market.
Which Segment Categories Define The Sickle Cell Disease Treatment Market?
The sickle cell disease treatment market covered in this report is segmented –
1) By Treatment Modality: Blood Transfusion, Pharmacotherapy, Bone Marrow Transplant
2) By Disease Type: Sickle Cell Anemia, Hemoglobin Sickle C Disease (HbSC), Other Disease Types
3) By Route Of Administration: Oral, Parenteral
4) By End-User: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By Blood Transfusion: Regular Blood Transfusion, Exchange Transfusion
2) By Pharmacotherapy: Hydroxyurea, L-Glutamine, Voxelotor, Crizanlizumab
3) By Bone Marrow Transplant: Allogeneic Transplant, Autologous Transplant
Which Trends Are Impacting The Growth Of The Sickle Cell Disease Treatment Market?
Major companies in the sickle cell disease treatment market are concentrating on developing new oral suspension drugs to improve patient adherence, enhance drug effectiveness, and provide more convenient treatment options, especially for pediatric and elderly patients. Oral suspension drugs are liquid medications containing solid particles mixed in a liquid, designed to make swallowing easier for patients, particularly children or those who find pills difficult. For instance, in March 2024, Akums Drugs and Pharmaceuticals Ltd., an India-based pharmaceutical preparation manufacturing company, introduced a room temperature-stable oral suspension of Hydroxyurea. This medication for SCD is an affordable, room-temperature-stable treatment developed to increase accessibility in India. Priced at less than 1% of imported options, it provides precise dosing with oral syringes, benefiting patients of all ages without needing cold storage.
Who Are The Top Companies Competing In The Sickle Cell Disease Treatment Market?
Major companies operating in the sickle cell disease treatment market are Sun Pharmaceutical Industries Ltd., Pfizer Inc., Johnson & Johnson Private Limited, Merck & Co Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Incorporated, Global Blood Therapeutics Inc., Acceleron Pharma Inc., Sangamo Therapeutics Inc., Medunik USA Inc., Zydus Cadila Healthcare Ltd., Graphite Bio Inc., Addmedica, Emmaus Medical Inc., Bluebird bio Inc., CRISPR Therapeutics AG, GlycoMimetics Inc., Mast Therapeutics Inc.
Read the full sickle cell disease treatment market report here:
https://www.thebusinessresearchcompany.com/report/sickle-cell-disease-treatment-global-market-report
How Is The Sickle Cell Disease Treatment Market Distributed Across Key Geographic Regions?
North America was the largest region in the sickle cell disease treatment market in 2025. The regions covered in the sickle cell disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Sickle Cell Disease Treatment Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=13048&type=smp
Browse Through More Reports Similar to the Global Sickle Cell Disease Treatment Market 2026, By The Business Research Company
Cells Therapy Global Market Report
https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report
Rare Diseases Treatment Global Market Report
https://www.thebusinessresearchcompany.com/report/rare-diseases-treatment-global-market-report
Cell Therapy Technologies Global Market Report
https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model